Document Detail


Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine.
MedLine Citation:
PMID:  8651964     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess the frequency and clinical features of an acute febrile toxic reaction (AFTR) in patients with refractory rheumatoid arthritis (RA) receiving combined therapy with methotrexate (MTX) and azathioprine (AZA). METHODS: A cohort of 43 RA patients being treated with MTX/AZA combination therapy were studied. In all of them, RA had been refractory to single-therapy disease-modifying antirheumatic drugs. We analyzed the frequency and clinical features of AFTR, which consisted mainly of the development of fever, leukocytosis, and cutaneous leukocytoclastic vasculitis when AZA was added to the MTX regimen. RESULTS: Four of the 43 patients (9.3%) who had been receiving long-term, well-tolerated treatment with MTX (mean +/- SD 375.5 +/- 159.5 days, range 227-561 days) developed AFTR shortly (mean +/- SD 25.7 +/- 13.6 days, range 17-46 days) after the addition of AZA to the regimen. The AFTR resolved rapidly (3 +/- 1.4 days) after discontinuation of AZA and MTX. In 2 cases, rechallenge with AZA and MTX was linked to a new flare of AFTR. CONCLUSION: The knowledge of this side effect is particularly important because it mimics a severe infectious complication related to immunosuppressive therapy, and because rechallenge can produce severe toxicity. Most of the new combined therapies for RA do not seem to be more toxic than single-drug treatment. Nevertheless, clinicians should be aware of a possible increase in side effects due to drug interactions or some other unidentified mechanism.
Authors:
R Blanco; V M Martínez-Taboada; M A González-Gay; J Armona; J L Fernández-Sueiro; M C González-Vela; V Rodríguez-Valverde
Related Documents :
24088534 - The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylax...
9489814 - Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
23683764 - Comparing the impact of supine and leg elevation positions during coronary artery bypas...
6432414 - Comparison of auranofin and aurothioglucose in the treatment of rheumatoid arthritis: a...
8708884 - Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflamma...
20868804 - Duration of acute kidney injury impacts long-term survival after cardiac surgery.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Arthritis and rheumatism     Volume:  39     ISSN:  0004-3591     ISO Abbreviation:  Arthritis Rheum.     Publication Date:  1996 Jun 
Date Detail:
Created Date:  1996-07-22     Completed Date:  1996-07-22     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0370605     Medline TA:  Arthritis Rheum     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1016-20     Citation Subset:  AIM; IM    
Affiliation:
Hospital Universitario M. Valdecilla, Universidad de Cantabria, Santander, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adult
Aged
Antirheumatic Agents / administration & dosage,  adverse effects*
Arthritis, Rheumatoid / drug therapy*
Azathioprine / administration & dosage,  adverse effects*
Cohort Studies
Drug Therapy, Combination
Female
Fever / chemically induced*
Humans
Leukocytosis / chemically induced*
Male
Methotrexate / administration & dosage*
Retrospective Studies
Time Factors
Vasculitis, Leukocytoclastic, Cutaneous / chemically induced*
Chemical
Reg. No./Substance:
0/Antirheumatic Agents; 446-86-6/Azathioprine; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A.
Next Document:  N-[4-hydroxyphenyl] retinamide in rheumatoid arthritis: a pilot study.